The MICA region determines the first modifier locus in familial Mediterranean fever

I Touitou1, M C Picot, C Domingo

  • 1Laboratory of Genetics, Arnaud de Villeneuve Hospital, Montpellier, France.

Arthritis and Rheumatism
|February 24, 2001
PubMed
Abstract

Insights

The major histocompatibility complex class I chain-related gene A (MICA) acts as a modifier locus for Familial Mediterranean fever (FMF). MICA influences disease severity and attack frequency, clarifying inconsistent MEFV gene correlations.

Area of Science:

  • Genetics
  • Immunology
  • Molecular Biology

Background:

  • Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder.
  • Mutations in the MEFV gene are the primary cause of FMF.
  • Inconsistent disease severity observed in FMF patients suggests the involvement of additional genetic factors.

Purpose of the Study:

  • To investigate the role of the major histocompatibility complex class I chain-related gene A (MICA) as a potential modifier gene in FMF.
  • To identify genetic factors contributing to the variable clinical presentation of FMF.

Main Methods:

  • Genetic analysis of 150 FMF probands and family members.
  • Screening of the MEFV gene using denaturing gradient-gel electrophoresis, restriction fragment length polymorphism, and amplification refractory mutation system.
  • Analysis of MICA transmembrane polymorphism in exon 5 using polymerase chain reaction and sequencing gels.

Main Results:

  • MICA was identified as a significant modifier locus influencing FMF phenotype, independent of patient ancestry and MEFV genotype.
  • M694V homozygosity in the MEFV gene exacerbated early disease onset when combined with MICA-A9.
  • The MICA-A4 allele was associated with a significant reduction in FMF attack frequency.

Conclusions:

  • MICA is the first identified modifier locus for FMF, establishing FMF as a model Mendelian disease associated with MICA.
  • These findings help explain the variable correlation between MEFV genotype and FMF phenotype.
  • MICA genotyping may aid in predicting FMF disease course and severity.